Skip to content

Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery

Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05171621
Acronym
MQUEST
Enrollment
50
Registered
2021-12-29
Start date
2019-10-16
Completion date
2021-10-31
Last updated
2021-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiretinal Membrane, Macular Holes, Metamorphopsia, Ophthalmologic Complication

Brief summary

Assessing metamorphopsia and quality of vision pre and post epiretinal and macular hole surgery

Detailed description

Metamorphopsia is a visual symptom in which straight lines appear distorted, for example a vertical window blind may appear wavy which can affect quality of vision. Metamorphopsia is a common symptom in retinal conditions such as epiretinal membranes (ERM) and macular holes. There is a lack of studies analysing the prevalence of ERM in the UK and Europe. Both of the conditions have shown to be a higher risk factor with age. With an aging population it is likely these numbers will increase. Currently the only treatment option is surgery (vitrectomy) or conservative management to monitor the condition. It would therefore be beneficial to find a tool that would inform the surgeon of a patient's quality of vision and how this impacts their life. A patient's severity of metamorphopsia reveals more precise information on the progression of the disease than visual acuity alone (Nomoto et al. 2013) therefore gaining a better understanding can help aid clinical decisions. Current clinical practice is to monitor metamorphopsia with an Amsler chart, a grid with lines; the patient is then asked to draw where they can see distortion. They are used to detect metamorphopsia but are unable to quantify and provide an accurate measurement of the severity of metamorphopsia and quality of vision The Quality of Vision questionnaire (QoV) (McAlinden et al. 2010) is a modern tool developed to specifically measure subjective quality of vision. The Metamorphopsia questionnaire (Arimura et al. 2011) has been developed to provide a measurement of subjective metamorphopsia in macular disease. Both have been psychometrically validated and are in use in a number of clinical trials worldwide. It would be valuable to investigate the role of each questionnaire in identifying quality of vison and metamorphopsia pre- and post-surgery for ERM and macular holes to establish if there are changes to patient responses. We would compare this to visual acuity and optical coherence tomography (OCT) images pre- and post-surgery to see if changes correspond to the questionnaire responses. If a questionnaire can measure metamorphopsia and its impact on quality of vision in ERM and macular holes, this would assist in clinical decision making.

Interventions

None listed

Sponsors

Hayley Westwood
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participant is willing and able to give informed consent * \>18 years old * Patients listed for epi retinal and macular hole surgery * Patient is able to perform study procedures

Exclusion criteria

* Patients who are diagnosed with a condition other than epiretinal membrane or macular hole * Patients not undergoing epiretinal or macular hole surgery * Patients will be excluded if there are any complications within surgery, or undergo any procedures that is not an epiretinal or macular hole surgery (i.e vitrectomy, phacoemulsification (lens extraction) as this can affect visual outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Compare the responses of the McAllinden and Metamorphopsia Questionnairepre surgery and 2 - 3 months post surgeryanalysing changes to responses in the 2 questionnaires pre and post surgery

Secondary

MeasureTime frameDescription
Changes to BCVA scorePre surgery and 2-3 months post surgeryPatients BCVA pre and post surgery to see if there is an improvement

Other

MeasureTime frameDescription
Assess correlations between the Mcallinden and Metamorphopsia questionnaire scores and objective clinical parametersPre surgery and 2-3 month post surgerydo the questionnaires show changes pre and post surgery and do they match clinical outcomes

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026